Influence of an intra-articular lipopolysaccharide challenge on markers of inflammation and cartilage metabolism in young horses.

The research article details a study which investigated the impact of inducing acute joint inflammation in young horses with intra-articular lipopolysaccharide and its effects on cartilage metabolism.

Study Overview and Design

• The research study utilized nineteen weanling Quarter Horses, grouping them by factors such as age, weight, and sex in a randomized block design.
• The animals were allocated into three groups each to receive different treatments: an intra-articular injection of 0.25 ng (n=7) or 0.50 ng (n=6) of lipopolysaccharide (LPS) obtained from Escherichia coli O55:B5, or a sterile lactated Ringer’s solution (n=6; control) into the radial carpal joint.
• This was designed as a 35-day experiment to investigate the effects of intra-articular LPS that induces acute joint inflammation in young horses.

Monitoring and Measurements

• The team gathered synovial fluid from the horses at regular intervals postinjection, which they then evaluated for varying biomarkers such as PGE2, CPII (carboxypeptide of type II collagen), and C2C (collagenase cleavage neopeptide) with commercial ELISA (enzyme-linked immunosorbent assay) kits.
• They also monitored the horses’ rectal temperatures, heart rates, respiratory rates, and carpal circumference before each sample was collected. The degree of the horses’ lameness was scored on a scale of 0 to 5 following arthrocentesis (joint fluid extraction).
• All these data were then processed for analytical interpretation using the PROC MIXED procedure of SAS (Statistical Analysis System).

Results and Interpretation

• The study found that clinical assessments of Heart rate, Respiration rate, and Rectal temperature were not significantly affected by the treatment.
• All horses showed an increase in lameness scores over time, and horses receiving LPS had higher recorded lameness scores at specific times postinjection, regardless of the LPS dose administered.
• Following injection, joint circumference increased across treatments in response to repeated arthrocentesis.
• An interesting finding revealed that the concentration of PGE2, a prostaglandin involved in inflammation, in the synovial fluid increased linearly with the dosage of administered LPS. This increase was observed to peak at 12 hours postinjection and remained above the baseline up to the 336-hour mark postinduction.
• The concentration of the CPII, an anabolic marker representative of collagen synthesis, likewise increased linearly with the LPS dosage and across the first 24 hours in all horses.
• C2C concentration in the synovial fluid was not significantly affected by treatment. It was observed to decrease from 0 to 6 hours and then steadily increase up to 24 hours in all horses.

Conclusion and Implications

• The outcomes of the study indicate that intra-articular administration of LPS succeeds in inducing joint inflammation and collagen synthesis in young horses in a dose-dependent manner.
• Such a model could be useful for investigating preventative strategies against joint disease in the young horse, offering insights into equine joint health and disease.